Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Operating Leases (2022 - 2025)

Historic Operating Leases for Biofrontera (BFRIW) over the last 4 years, with Q3 2025 value amounting to $136000.0.

  • Biofrontera's Operating Leases fell 5802.47% to $136000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $136000.0, marking a year-over-year decrease of 5802.47%. This contributed to the annual value of $276000.0 for FY2024, which is 6567.16% down from last year.
  • As of Q3 2025, Biofrontera's Operating Leases stood at $136000.0, which was down 5802.47% from $223000.0 recorded in Q2 2025.
  • Biofrontera's 5-year Operating Leases high stood at $848000.0 for Q4 2022, and its period low was $136000.0 during Q3 2025.
  • Moreover, its 4-year median value for Operating Leases was $443000.0 (2024), whereas its average is $471090.9.
  • In the last 5 years, Biofrontera's Operating Leases crashed by 518.87% in 2023 and then plummeted by 6567.16% in 2024.
  • Over the past 4 years, Biofrontera's Operating Leases (Quarter) stood at $848000.0 in 2022, then fell by 5.19% to $804000.0 in 2023, then tumbled by 65.67% to $276000.0 in 2024, then tumbled by 50.72% to $136000.0 in 2025.
  • Its Operating Leases stands at $136000.0 for Q3 2025, versus $223000.0 for Q2 2025 and $220000.0 for Q1 2025.